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Abstract: Aging is a natural biological process that manifests as the progressive loss of function
in cells, tissues, and organs. Because mechanisms that are meant to promote cellular longevity
tend to decrease in effectiveness with age, it is no surprise that aging presents as a major risk
factor for many diseases such as cardiovascular disease, neurodegenerative disorders, cancer, and
diabetes. Oxidative stress, an imbalance between the intracellular antioxidant and overproduction of
reactive oxygen species, is known to promote the aging process. Autophagy, a major pathway for
protein turnover, is considered as one of the hallmarks of aging. Given the progressive physiologic
degeneration and increased risk for disease that accompanies aging, many studies have attempted to
discover new compounds that may aid in the reversal of the aging process. Here, we summarize the
antiaging mechanism of natural or naturally derived synthetic compounds involving oxidative stress
and autophagy. These compounds include: 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO)
derivatives (synthetic triterpenoids derived from naturally occurring oleanolic acid), caffeic acid
phenethyl ester (CAPE, the active ingredient in honey bee propolis), xanthohumol (a prenylated
flavonoid identified in the hops plant), guggulsterone (a plant steroid found in the resin of the
guggul plant), resveratrol (a natural phenol abundantly found in grape), and sulforaphane (a sulfurcontaining compound found in cruciferous vegetables).

doi.org/10.3390/molecules27144396
Academic Editor:
Guglielmina Froldi

Keywords: aging; oxidative stress; autophagy; CDDO derivatives; CAPE; xanthohumol; guggulsterone; resveratrol; sulforaphane

Received: 3 June 2022
Accepted: 6 July 2022
Published: 8 July 2022
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affiliations.

Copyright: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/

1. Introduction
Aging is generally defined as the process of growing old, which consists of a deterioration of organelles brought about by an increase in reactive oxygen species and a
decrease in autophagy, which is responsible for flushing out damaged cells. However,
there is no consensus definition for the term aging, reflecting the lack of understanding of
the phenomenon itself. To understand the fundamental mechanisms that regulate aging,
the science community came up with the theory of aging: the oxidative stress theory of
aging (OSTA) [1]. The OSTA is the most well-known and studied mechanistic theory of
aging and suggests that the rate of aging is regulated by the accumulation of oxidative
damage. The development of aging is a multifactorial process [2,3]. According to the
theory, there are two categories that contribute to the development of chronic diseases and
premature aging: the accumulation of molecular and cellular oxidative damages in all tissues throughout life and the disruption of immune response homeostasis, characterized by
increased pro-inflammatory stimuli and a decreased anti-inflammatory response [2,4,5]. In
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addition, research over the last decade has demonstrated that many molecular changes associated with aging are caused by the altered autophagy across diverse species. Autophagy
(from the Greek words auto, meaning ‘self’, and phagein, meaning ‘to eat’) is a complex
pathway that removes cellular components, such as defective organelles and misfolded
proteins, through lysosomes. The effect of autophagy regulation on tissue homeostasis has
been actively investigated in recent research, which revealed a complex and multifactorial
relationship between autophagy and aging.
In recent years, many researchers aimed that autophagy is a druggable target, and
modulating the autophagy processes can be a promising therapeutic opportunity for
antiaging effects [6–9]. Pharmacological agents such as metformin, rapamycin, spermidine,
and tomatidine have been extensively studied and reviewed as autophagy inducers that
extend the health span and increase the lifespan of laboratory animals [10–14]. However, in
terms of promoting longevity and antiaging effects, natural products and phytochemicals
without side effects are preferred over pharmacological agents.
Scientific research on the potential for a variety of natural compounds and phytochemicals of health benefits has expanded rapidly over the past decade. Phytochemicals are a
group of a wide variety of compounds that occur naturally in plants, which includes fruits,
vegetables, grains, and other plant food [15]. Phytochemicals produce activity in biological
systems, including humans. They consist of nutrients essential for optimal health (e.g.,
proteins, carbohydrates, vitamins, and minerals) and other chemicals (e.g., phenolic acids,
flavonoids, and other phenolics) [16]. These chemicals in plants play crucial roles in their
growth and development. They protect plants from harmful agents, such as insects and
microbes, as well as environmental factors, such as ultraviolet irradiation and extreme temperatures [17]. Moreover, a number of these phytochemicals are found to have beneficial
health effects when consumed. Preclinical, clinical, and epidemiological research suggests
that phytochemicals may be effective in treating various diseases owing to their antioxidant and anti-inflammatory activities [18]. Numerous research groups have shown that
phytochemicals work by targeting specific receptors, interrupting disease pathways, and
disrupting pathogenic life cycles. Some of these natural compounds have been developed
into pharmacological agents such as salicylates found in willow bark, quinine in cinchona
bark, and proanthocyanidins in cranberries [17].
About 10,000 different phytochemicals have been identified, and a large percentage
of these compounds still remain unknown with respect to chemical structure and/or the
biological role in humans [19]. Generally, phytochemicals have been classified into six major
categories based on their chemical structures and characteristics. These categories include
carbohydrate, lipids, phenolic, terpenoids, and alkaloids, and other nitrogen-containing
compounds [15]. Within each category, further division based on biogenesis or biosynthetic
origin gives rise to different subcategories. Among these phytochemicals, antioxidant-rich
phytochemicals in each category have been chosen to provide a further explanation of the
biological activities, focusing on autophagy and antiaging effects.
In this review, six compounds were chosen from different categories of phytochemicals: three from polyphenols, one from terpenoids, one from alkaloids, and one from
phytosterols (lipids). Polyphenols represent the largest category of phytochemicals and
serve as powerful antioxidants due to their multiple hydroxyl groups [20]. Examples are
carbonic acid, curculigoside, curcumin, rosmarinic acid, tectorigenin, tyrosine, etc. In this
review, three compounds were chosen from polyphenols which are further classified as
three categories: phenolic acids (CAPE), flavonoids (xanthohumol), and other phenolics
(resveratrol). Furthermore, CDDO represents the terpenoids group, and guggulsterone
falls into a phytosterol classification. Lastly, sulforaphane is an alkaloid phytochemical.
Due to an increase in the interest in natural products and phytochemicals in recent
years, the role of natural compounds in modulating reactive oxidative species (ROS) and
autophagy processes became a popular topic in scientific communities [21–23]. ROS refers
to a number of oxygen-containing molecules and radicals that are produced through
the oxidative metabolism within mitochondria or in response to external stimuli such as

Molecules 2022, 27, 4396

3 of 24

xenobiotics and bacterial invasion [24]. Of the major ROS, the superoxide anion (O2 •− )
usually serves as the starting point to form other free radicals, including hydrogen peroxide (H2 O2 ) and the hydroxyl radical (HO• ) [25]. In a recent review paper published by
Thoma et al., they stated that the aberrant generation of ROS was directly related to the
age-related loss of muscle mass, and effective targeted therapies can be developed [26]. The
study included a few examples of vitamins and phytochemicals which target and regulate
the ROS generation [27,28]. One of the examples is resveratrol; many studies demonstrated
its capability of inhibiting lipid peroxidation and increasing catalase and superoxide dismutase activity [29,30]. Thus, it is worthy to investigate other phytochemicals’ antiaging effects
through modulating the process of autophagy and the abnormal generation of reactive
oxygen species.
The skin is the biggest organ of the human body and provides a physical barrier against
exogenous factors such as ultraviolet radiation, microorganisms, and toxic substances [31].
The skin is composed of cells from several different systems of the organisms, such as
the nervous, immune, circulatory, and endocrine systems. Evidently, skin senescence is
closely related with organismal aging and age-related dysfunctions [32–35]. Therefore,
understanding the impact of cell senescence on promoting systemic aging could result in
new approaches to delay skin aging and age-related disorders. Skin aging is related to
intrinsic factors and external agents; in both cases, the involved mechanisms are related to
the malfunction of skin tissue cells, which lead to degradation of skin tissues. These changes
come from the reduction in epidermal proliferation and extracellular matrix components
synthesis, which are the result of imbalances of mechanisms explained above: the OSTA
and homeostasis of autophagy.
In this paper, the role of reactive oxygen species and autophagic pathways related
to the aging process will be thoroughly reviewed as well as introduce potential natural
compounds that may promote antiaging effects by modulating reactive oxygen species
and autophagy pathways. The effect of each compound on skin aging and skin health
benefit will be briefly discussed, including in vitro and in vivo studies using different skin
models. The compounds included in this paper are 2-cyano-3,12-dioxoolean-1,9-dien28-oic acid (CDDO) derivatives (synthetic triterpenoids derived from naturally occurring
oleanolic acid), caffeic acid phenethyl ester (CAPE, the active ingredient in honey bee propolis), xanthohumol (a prenylated flavonoid identified in the hops plant), guggulsterone (a
plant steroid found in the resin of the guggul plant), resveratrol (a natural phenol abundantly found in grape), and sulforaphane (a sulfur-containing compound found in cruciferous vegetables).
2. Autophagy and Aging
Autophagy is the process by which eukaryotic cells selectively degrade and recycle misfolded, damaged, or excessive cytosolic products, including organelles and proteins [36]. While this process is present in basal conditions, autophagy is stimulated in
the presence of stressors such as low nutrients or oxidized proteins. It is both a protective
and adaptive mechanism that repurposes potentially toxic cytosolic proteins into necessary macromolecules that can be used to make energy [37]. Autophagy has three forms:
microautophagy, macroautophagy, and chaperone-mediated autophagy (CMA) [38]. Because this process is degradative and changes in response to many stimuli, each step is
tightly regulated.
Macroautophagy, the most common pathway of autophagy, is a multistep mechanism
that begins with sequestering the organelles and proteins that will be sent for degradation. It is well-established that sequestering occurs through the formation and elongation
of a double-membraned structure that may be referred to as an autophagosome or a
phagophore. Once this de novo structure is formed, the autophagosome takes the products
to be degraded to the lysosomes and fuses with it so that the lysosomal hydrolases can
break down the contents [39,40]. The by-products of this process are formed into TCA-cycle
intermediates that can be used to provide nutrients and generate energy. Each step of
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autophagy is tightly regulated by signaling proteins that respond to the amount of available
nutrients. A lack of nutrients or starvation will initiate the process of autophagy.
There are several key protein complexes that initiate and regulate the phases of
macroautophagy. Unc-51-like autophagy-activating kinase 1 (ULK1), a serine/threonine
kinase and the mammalian functional homolog of yeast ATG1, is known to play a central
role in initiating autophagosome formation during early autophagy [41,42]. ULK1 is a
kinase complex with several protein partners, including ATG13, ATG101, and FIP200
(the focal adhesion kinase family interacting protein of 200 kDa) [43]. These proteins are
targets of phosphorylation by AMP-activated protein kinase (AMPK) and the mammalian
target of rapamycin (mTOR) [41,44]. When ATP is low, the nutrient sensor AMPK directly
phosphorylates ULK1 which then initiates autophagy. This direct phosphorylation by
AMPK is inhibited by mTOR when there are sufficient nutrients or in the presence of
growth factors [45]. In essence, AMPK and mTOR oppositely regulate ULK depending on
the availability of nutrients.
Other proteins that are a part of the autophagy apparatus have been used to provide
insight into an organism’s ability to properly carry out autophagy within its cells. One
example is the role of p62 in selective autophagy. In this case, p62 serves as a linking
protein that directs ubiquitinated proteins to the autophagosome for degradation [46]. In
order to carry out its function as an adapter, it first associates with LC3-II, a docking site
for p62 bound to ubiquitinated substrates, within the growing phagophore. Once p62 has
performed this task, it is later degraded within the lysosome. Because p62 levels should
decrease with increased autophagy, the accumulation of p62 can serve as an indicator of
poorly functioning autophagy machinery. The conversion of LC3 to LC3-II can also be
evaluated in conjunction with p62 levels. Moreover, p62 has the ability to interact with
major cellular control “switches” such as the nuclear factor-erythroid 2 p45-related factor 2
(Nrf2), caspases, and tumor necrosis factor (TNF)-α [47,48]. Taken together, depending on
the levels of p62, the rate of autophagic turnover can influence other cellular mechanisms
such as cell death, survival, and ROS regulation. Conversely, cellular stress and ROS
accumulation may influence autophagy.
The other two forms of autophagy, microautophagy and CMA, also play a role in
maintaining cellular homeostasis and function to complement macroautophagy. While
maintaining the basic principle of proteomic recycling and degradation, microautophagy
occurs through lysosomal invagination and the engulfment of cytosolic materials. Similar
to macroautophagy, the process of microautophagy has been shown to be activated through
nutrient deprivation and mTOR inhibitors such as rapamycin in mammalian tissues. The
molecular mechanisms of microautophagy are not well-known in mammals; however,
yeast studies have provided some insight. It has been shown that selective microautophagy
utilizes hsc70 (the heat-shock cognate protein of 70 KDa), a cytosolic chaperone protein,
in the early stages. CMA also utilizes cytosolic hsc70, which plays a role in targeting and
directing the substrate proteins to the lysosome. Proteins are selected for degradation
by the amino acid sequence, KFERQ, found within the proteins primary structure [49].
The proteins are then delivered to the cytosolic tail of the lysosome-associated membrane
protein type 2A (LAMP-2A) receptor where the substrate protein is unfolded [50]. LAMP2A then undergoes multimerization to allow translocation of the substrate protein into the
lysosome for degradation. Because CMA and endosomal microautophagy are stimulated
by stress or lack of nutrients, they often work in concert with macroautophagy to maintain
the cells’ ability to constantly adapt.
As mammals age, the process of autophagy becomes less efficient and leads to the
accumulation of potentially toxic cytosolic constituents. When the ability of cells to regulate potentially toxic levels of cytoplasmic proteins is diminished, it becomes easier for
disease processes to emerge. Diseases in multiple systems have been related to decreased
autophagy [51]. There is increased evidence that decreased autophagy leads to aging
among different organisms. Studies that have been performed in model organisms such
as yeast, nematodes, and fruit flies have shown that interfering with Atg genes and, by
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extension, macroautophagy significantly decreases lifespan [52–54]. There have been over
30 Atg (autophagy-related) genes discovered in yeast that are responsible for regulating this
process [55]. Yeast Atg genes have served as a model for studying autophagy regulation in
mammals. These Atg homologues are present throughout the early events of autophagy
induction through association with Beclin-1 and the recruitment of additional ATG proteins.
In macroautophagy, ATG proteins play a key role in autophagosome formation and elongation through association with LC3 (microtubule-associated protein 1 light chain 3), a critical
component in autophagosome formation [56]. Mice models have also been used to reveal
the critical role that autophagy plays in lifespan. Selective deletion of Atg5, Atg7, Atg16L1,
and Beclin, in mice, provided further insight into the importance of autophagy improving
lifespan [57–60]. Changes in the negative regulator of autophagy, mTOR, have also been
related to aging. As previously mentioned, mTOR is a nutrient sensor that is activated
through phosphorylation when nutrients are high which, in turn, inhibits autophagy. It has
been shown that the inhibition of mTOR promotes longevity in yeast and fruit flies. Aging
organisms are associated with hyperphosphorylation of mTOR, which would lead to its
hyperactivation, and inhibition of autophagy [61–63]. This would limit the cell’s ability to
rid itself of oxidized proteins and maintain nutrient balance.
One of the hallmarks of aging is the progressive lack of function of normal cellular
machinery, which makes a way for pathologies to emerge. There is mounting evidence that
macroautophagy plays a critical role in maintaining normal neurological function. Because
autophagy maintains protein turnover, it is necessary in order to prevent disorders such as
Alzheimer’s disease and Parkinson’s disease, whose pathogenesis have been well-linked to
the accumulation and aggregation of proteins [64]. Alzheimer’s disease is a form of dementia that is marked by the presence of senile plaques and intra-neuronal fibrillary tangles.
These plaques are composed of toxic proteins and beta amyloid peptides. The reason these
plaques accumulate is due to the hyperphosphorylation of Tau, a microtubule-associated
protein, which stabilizes and therefore inhibits normal microtubule dynamics [65]. Because
vesicular movement cannot occur without proper microtubule turnover, these plaques
become trapped within the vesicles that are formed during the early events of autophagy
and begin to accumulate. This further provides evidence that decreased autophagy plays a
key role in the pathogenesis of this neurodegenerative disorder. Parkinson’s disease is a
devastating movement disorder that gets progressively worse over time. Its pathogenesis
is due to neuronal cell death in the substantia nigra and accumulation of alpha-synuclein.
It has been shown that the degeneration of autophagy (both macroautophagy and CMA)
plays a role in the development of Parkinson’s disease [66,67]. There have been studies
highlighting the decreased expression of major CMA components LAMP2A in patients
with this disease. There have been many studies confirming that CMA markedly decreases
with age, primarily through the decreased presence of functional LAMP2A. With a better
understanding of the interplay between autophagy and aging, we can develop therapeutics
to target these molecular changes.
Lastly, it is important to note that apoptosis and autophagy are closely related molecular processes, which maintain organismal and cellular homeostasis. Whereas autophagy
maintains cellular homeostasis by recycling selective intracellular organelles and molecules,
apoptosis fulfills its role through dismantling damaged or unwanted cells. In this review, we highlighted the antiaging effects of those natural compounds that demonstrated
organismal and cellular homeostasis through autophagy and apoptosis.
Two distinct pathways are responsible for the induction of apoptosis: intrinsic and
extrinsic pathways. The release of cytochrome c into the cytosol activates the intrinsic
pathway, which leads to cytochrome c binding to and forming a complex with Apaf-1,
causing caspase-9 to be activated. The activation of caspase-9, in turn, activates caspase-3.
The extrinsic pathway begins with stimulation of the TNF family of death receptors which
leads to the activation of caspase-8, resulting in the direct activation of caspase-3 [68].
It is worth to note that the compounds that are included in this review utilize both au-

Molecules 2022, 27, 4396

6 of 24

tophagy and apoptosis pathways to maintain organismal and cellular homeostasis to
promote longevity.
3. Oxidative Stress and Aging
ROS are molecules constantly being generated through both cellular metabolism
in the mitochondria and exposure to various environmental stimuli [69]. ROS include
both radical (superoxide anion and hydroxyl radical) and nonradical species of oxygen
(hydrogen peroxide). “Free radicals,” which refers to atoms with unpaired electrons, are
highly reactive and can cause oxidative damage in tissues. During cellular respiration, the
inefficient transfer of electrons between molecules allows for some electrons to slip through
and bind with oxygen, thus forming these “free radicals” [70]. Once a radical has been
produced, it can be converted to a non-radical form, or it can interact with other components
of the cell and cause damage. Because of the deleterious effects of ROS accumulation, the
body has both enzymatic and non-enzymatic antioxidant systems in place to prevent ROS
from rising to a harmful level. When the oxidant and antioxidant systems are out of balance,
oxidative stress that may damage the cells is generated [71]. The damage produced by
oxidative stress has been implicated not only in many human diseases but in the process of
aging as well.
As the key player in metabolism, mitochondria are the major producers of reactive
oxygen species [72]. Given the proximity of mitochondrial DNA to ROS production, some
studies suggest that mitochondrial DNA is more susceptible than other genetic materials to
ROS-induced damage and mutations [73]. Mitochondrial DNA encodes for proteins used
for the regulation of critical processes such as oxidative phosphorylation and apoptosis.
It is inferred that increased mutations in these regions may lead to the malfunctioning of
these processes, and thus the generation of more ROS that ultimately leads to cell death [74].
Studies have shown that dysfunctional mitochondria and increased production of oxidative
stress play a large role in the pathophysiology of neurodegenerative diseases, including
Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease [75]. Overall, aging
and age-related diseases are strongly related to mitochondrial decline.
As mentioned before, the accumulation of free radicals and ROS has the tendency to
cause oxidative damage to organelles and other macromolecules such as proteins, lipids,
and DNA—this has been termed the oxidative stress theory of aging [71,76]. It has been
proposed that the overproduction of ROS promotes cellular senescence, a state that occurs
as a response to cellular damage and stops proliferation. The increased ROS accumulation
is reported to enhance telomere shortening which has the most correlation with cellular
senescence [77]. This senescent state is associated with a number of secretory proteins
that play roles in age-related disease. Inducing senescence in stem cells that are necessary
for the regeneration and repair of damaged tissues can impede an organism’s ability to
maintain homeostasis and promote longevity. It has been well-documented that with age,
stem cells lose their ability to regenerate [78–81]. In addition, studies using animal models
demonstrate that increased ROS production leads to a decline in stem cell renewal. In one
study using a mouse model, researchers deleted the Ataxia telagiectasia-mutated (ATM)
kinase gene in hemopoietic stem cells (HSC) [82]. The deletion of the ATM kinase resulted
in increased ROS and a decreased ability for cellular renewal. However, the oxidative stress
was ameliorated using antioxidant N-acetylcysteine and led to regaining function of those
cells. This suggests that the accumulation of ROS could be the main factor that caused the
decline in the HSC function.
The generation of ROS can also interact with a number of transcription factors and
regulatory proteins. A key regulatory factor of redox balance is the Nrf2-Kelch-like ECHassociated protein 1 (Keap1) system, which upregulates genes that are responsible for
antioxidant functions [83]. The transcription factor, Nrf2, binds to the promoter region of
antioxidant response elements which is involved in cytoprotective mechanisms, including
DNA repair, proteostasis, and the prevention of apoptosis. When Nrf2 functions are low,
ROS accumulation is unchecked, and cells become more sensitive to oxidative stress [84].
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The decreased function of Nrf2 has been shown to promote molecular mechanisms that are
representative of aging, such as telomere shortening, genomic instability, mitochondrial
dysfunction, and cellular senescence [85–88].
Telomerase reverse transcriptase (TERT) is a protein associated with promoting telomere extension. Recently, it has been shown that increased Nrf2 expression is associated with
increased TERT expression, and thus continuous cellular division [85]. As reported before,
Nrf2 was reported to prevent genomic instability through promoting DNA repair [86,87].
With age, DNA repair mechanisms such as replication errors and base excision repair
occur at a much higher rate which leads to a number of pathological conditions [89]. As
previously mentioned, mitochondrial accumulation of ROS and mitochondrial dysfunction
increased with aging. As an antioxidant-promoting transcription factor, Nrf2 plays an
important role in maintaining redox balance within the mitochondria. It has also been
shown that downregulation of Nrf2 could be associated with cellular senescence. In a study
using fibroblasts, Kasai et al. suggested that younger cells were less sensitive to oxidative
stress when compared with the older ones [90]. When treated with a Nrf2 activator, the
older cells were less sensitive to oxidative stress. Taken together, it is well-established that
Nrf2 is an important player maintaining oxidative balance, homeostasis, and thus longevity.
The production of ROS is a continuous process that becomes less efficient with age.
The presence of ROS has multifaceted effects on cellular function and generation of disease.
Transcription factors such as Nrf2 play a key role in maintaining antioxidant function to
keep oxidative stress at a minimum. When master regulators like Nrf2 decline in activity
with age, the organisms are more sensitive to oxidative stress, which leads to aging-related
pathophysiological conditions and disorders. Understanding the important role ROS play
in aging leads to antioxidants as a potential remedy in the prevention and treatment of
aging-related diseases.
4. Antiaging Compounds
Compounds derived from various plant sources have been used widely around the
world for many centuries as an alternative remedy for chronic and aging-related diseases.
In this section, we evaluated the action and mechanism of several phytochemicals on
oxidative stress, autophagy, and other aging-related conditions. These phytochemicals
include CDDO derivatives, caffeic acid phenethyl ester, xanthohumol, guggulsterone,
resveratrol, and sulforaphane with their structures presented in Figure 1.
4.1. CDDO Derivatives
Triterpenoids are naturally occurring compounds that can be found in the wax-like
covering of fruits, such as apples, figs, cranberries, and olives, and herbs, such as lavender, oregano, thyme, and rosemary. These compounds, which are formed through the
cyclization of squalene, resemble steroids in structure and have been used for centuries
due to their antibacterial, anti-fungal and anti-inflammatory properties [91]. Oleanolic
acid, which is primarily extracted from olive leaves, is a pentacyclic triterpenoid that has
been shown to display weak anti-inflammatory effects. In an attempt to strengthen these
effects, synthetic derivatives were created more than 20 years ago, including 2-cyano-3,12dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its C28-modified derivative, methyl-ester
(CDDO-Me, also known as bardoxolone methyl) [92]. CDDO and CDDO-Me have been
shown to display potent anticancer effects through the inhibition of processes that promote
proliferation, angiogenesis, and metastasis.
As mentioned above, there are three major mechanisms of autophagy: macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA), which involve the
delivery of substrates to the lysosome for degradation. Recent studies have identified
CDDO derivatives may inhibit necroptosis by promoting the process of CMA via inhibition
of heat shock protein 90 (Hsp90).
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Initially, CDDO was developed as a highly potent anti-inflammatory agent based
on the structure of oleanolic acid. The poor oral bioavailability of CDDO ultimately led
to many other derivatives being synthesized, including CDDO-Me (methyl ester) and
CDDO-Im [100,101]. The health benefits of these molecules are getting more attention
from the science community due to anti-inflammatory, antioxidant, and anti-angiogenic
properties [102–105].
Both in vivo and in vitro studies demonstrated multiple pathways in the regulation
of angiogenesis [96,100,106]. Currently, there are three known mechanisms of action of
CDDO-Me and CDDO-Im that relate to the regulation of angiogenesis. The first target
is the suppression of NF-κB signaling, which leads to the suppression of angiogenesis.
Both CDDO-Me and CDDO-Im have been shown to possess potent inhibition activities
of IκB kinase, which activates NF-κB. The second target is the suppression of the Signal
Transducer and Activator of Transcription (STAT) signaling, as mediated by the ability of
both CDDO-Me and CDDO-Im to suppress the phosphorylation of both STAT3 and STAT5,
which is required for the activity of these proteins as transcription factors. STATs are known
to play an important role in mediating both wound healing and angiogenesis. A third
important pathway regulated by synthetic oleanane triterpenoids is transforming growth
factor-h/BMP/Smad signaling which, in turn, allows the triterpenoids to enhance their
transcriptional activity of the respective Smads that are involved in regulating gene activity.
There is plenty of evidence for the role of this transforming growth factor signaling as a
critical regulator of both wound healing and angiogenesis. A fourth molecular target of
CDDO-Me is Keap1, the endogenous inhibitor of the transcription factor Nrf2, although
the effects of genes regulated by Nrf2 on the process of angiogenesis is still unclear [106].
The skin is one of the organs that shows obvious and visible signs of aging when one
becomes older. Therefore, promoting antiaging effects on the skin has earned tremendous
interest in recent decades. Physiological processes and molecular pathways that induce
cutaneous aging are related to other cellular pathways. For example, a decrease in the
autophagy process within the basal cell layer results in a reduction in the proliferative ability
of cells, including keratinocytes, fibroblasts, and melanocytes [107]. Moreover, ROS play a
critical role in skin aging by inhibiting the activity of protein tyrosine phosphatases and
triggering downstream signaling pathways, including the activation of mitogen-activated
protein kinase (MAPK) and subsequent NF-κB and transcription factor activator protein1 (AP-1) [108–110]. In addition, senescence of skin keratinocytes are increased due to
oxidative stress caused by the elevation of LC3-II and p63 protein levels [111]. Many in vitro
and in vivo studies showed that oleanolic acid derivatives are powerful inhibitors for
oxidative stress caused by the induction of NO synthase and cyclooxygenase 2 [110,112,113].
Choi et al. used a murine model to show CDDO derivatives decreased skin lesions and
the infiltration of immune cells caused by ROS. Kim et al. also demonstrated that CDDO
derivatives decreased the autophagy process in keratinocytes by evaluating the protein
expression of LCE-II and p62 by Western blotting [113].
Evidence from the collected data suggested that CDDO and CDDO derivatives actively
modulate the bioactive molecules that are responsible in the pathogenesis of antiaging
processes such as autophagy and oxidative stress. A major molecular pathway that CDDO
promotes the initiation of the autophagy process is upregulating the transcription factor
Nrf2 and transcription factor EB (TFEB). Moreover, it promotes longevity by modulating
many inflammatory mediators such as Keap1 and iNOS. Based on this evidence, clinical
trials are needed to explore CDDO and its derivatives effects for the purpose of future
therapeutic modalities.
4.2. Caffeic Acid Phenethyl Ester (CAPE)
Caffeic acid phenethyl ester (CAPE) is a naturally occurring compound with many
known healing effects on the human body. The full chemical of CAPE is 2-phenylethyl
(2E)-3-(3,4-dihydroxyphenyl) acrylate. It can be extracted and purified from the beehive
propolis, which is a substance collected from various plant sources by honeybees [114].

Molecules 2022, 27, 4396

10 of 24

Although CAPE is a naturally occurring hydrophobic polyphenol, it can also be prepared
through enzymatic synthesis [115–118]. CAPE has been shown to provide numerous
beneficial effects, in both in vitro and in vivo studies, through its ability to function as
an anti-inflammatory, antioxidant, and an anti-tumor agent. The bioactivity of CAPE
is largely attributed to the presence of the catechol ring and hydroxyl groups within its
structure [119,120]. Through structural modifications of the catechol ring, several studies
have highlighted its importance to CAPE’s overall function and activity.
To add to the multifaceted beneficial effects of CAPE, there have been studies linking
this propolis extract to mechanisms of autophagy. The nature of CAPE’s role in autophagy
may be dependent on the physiological state of the cell. There have been several cancer
studies highlighting CAPE and its derivatives to upregulate autophagy activity. In the
human neuroblastoma cell line SH-SY5Y, treatment with CAPE was shown to induce
autophagy activity [121]. Through Western blot, this study found increased expression
of the LC3-II protein, an important constituent of the autophagosome structure, after
treatment with CAPE for 4, 8, and 12 h. Similarly, a study conducted using breast cancer
cell lines MDA-MB-231 found that CAPE caused an increase in LC3-I to LC3-II conversion
and upregulation of LC3-II in cells that were LPS-stimulated [122]. CAPE has also been
shown to induce autophagy in a liver fibrosis study which utilized both in vivo and in vitro
models. In this study, CAPE ameliorated the CCl4-induced liver fibrosis by inhibiting
the TGF-β/Smad pathway. Additionally, CAPE induced autophagy in HSC cell lines and
thereby prevented fibrosis. Evidence of CAPE’s autophagy activation was measured in
HSC-T6 cells through immunofluorescent visualization of autophagosome formation and
Western blot analysis of autophagy markers such as LC3II, ATG7 and BECLIN 1. Because
there was decreased expression of pAKT and pmTOR, it was suggested that CAPE’s
induction of autophagy was through the inhibition of AKT/mTOR signaling.
Other derivatives of CAPE have been observed to alter autophagy mechanisms in
cancer cell lines. One such derivative, phenethyl caffeate benzoxanthene lignan (PCBL),
was shown to increase autophagy in WiDr colorectal adenocarcinoma cells [123]. PCBL
also increased both BECLIN 1 expression in Western blot analysis and autophagic flux in
WiDr cells. Further experimentation suggested that PCBL induced autophagy through
a class III PI3-kinase-dependent manner, also known as the canonical pathway, rather
than through mTOR regulation. In addition, increased autophagic activity in glioma cells
through increased expression of LC3-II and decreased p62 expression was observed after
PCBL treatment [123].
Many studies have shown that phytochemicals have the potential to offer antiaging
properties through scavenging reactive oxygen species, enhancing production of antioxidants, and maintaining the cytosolic balance of proteins [124]. In a study using Caenorhabditis elegans, CAPE was shown to promote longevity and resistance to stress through the
modulating insulin-like DAF-16 pathway, a mechanism responsible for regulating oxidative
stress in nematodes [125]. In this study, CAPE significantly increased DAF-16 translocation
into the nucleus which indicates increased activity of the transcription factor. DAF-16 also
appeared to play a role in promoting longevity, as lifespan was significantly decreased in
the DAF-16 loss-of-function mutant C. elegans. After treatment with CAPE, the accumulation of ROS was significantly decreased. Similarly, CAPE reduced ROS, increased lifespan,
and increased activity of the transcription factor, Nrf2, in human Hct116 cells.
There is a plethora of evidence that ROS accumulation promotes aging [74,76]. To
investigate the role of antioxidants in the amelioration of ROS-induced aging, CAPE and
melatonin were used in a mouse model to observe its effects on cardiovascular aging [126].
After CAPE and melatonin were administered to the aged mice, the heart tissues were
evaluated through histological observations, antioxidant enzyme assays, and protein determination through absorbance measurements. The authors found that CAPE increased
expression of antioxidant enzymes and reduced age-related ultrastructure modifications in
the heart and aorta. This study concluded that CAPE could play a role in reversing and
delaying the aging process in the cardiovascular system.
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Antiaging research related to ultraviolet (UV) rays and how they can damage skin
have received remarkable spotlights. Solar UV exposure is a major causative factor for
age-related changes of skin, such as wrinkles and cancer development. In other words, UV
radiation can induce skin pathologies, including erythema and inflammation, degenerative
aging change, and cancer [127]. UV radiation produces both direct and indirect DNA
damage, which can result in mutagenesis in skin cells [128]. In recent studies, CAPE was
found to possess various activities such as antimicrobial, antioxidant, anti-inflammatory,
and cytotoxicity activities. These activities were demonstrated by evaluating CAPE’s ability
to suppress ROS levels in different cells and tissues [129–133]. Shin et al. demonstrated that
CAPE could block UV-stimulated matrix metalloproteinase-1 (MMP-1) levels in skin cells
and in human skin tissues by inhibiting histone acetyltransferase activity, which may lead
to the attenuation of non-histone proteins and histone H3K9 acetylation. Therefore, CAPE
may prevent skin aging caused by UV exposure [128]. Extensive literature is available on
the antiaging effects of CAPE, but still some areas require to be explored, such as pre-clinical
and clinical studies. Further investigation to use this data of CAPE’s bioactive activities to
become a therapeutic treatment of ailments is required.
4.3. Xanthohumol
Hops flowers (Humulus lupulus L.) have been used widely in the brewing of beer
to give it the characteristic bitter flavor and aroma. Besides being used in beer brewing,
hops flowers contain a bioactive substance called xanthohumol (XN). XN is found in
the trichomes on the hop leaves and secreted as part of the hop resin, with a content of
0.1–1% dry weight [134]. The traditional extraction of XN was performed by repeated
chromatographic steps on silica gel using different solvents. This has been converted to a
more time-efficient isolation and purification method by developing a high-speed countercurrent chromatography. XN, which is a prenylated flavonoid derived from the female
inflorescences of the hops, has been used for its diverse pharmacological properties which
may include: anticancer, antiaging, antibacterial, anti-inflammatory activities, etc. [135].
XN has been extensively researched and has shown efficacy in regulating several
pathways related to proliferation, apoptosis, as well as having the ability to inhibit NF-κB
and Akt (protein kinase B) activation in vascular endothelial cells. Some studies have
shown that XN contributes to the prevention of oxidative damage by reducing ROS and
NO production. Another pathway that it acts upon is the inhibition of cyclooxygenase
activity which leads to anti-inflammatory effects [136]. XN is able to induce cell-cycle arrest
leading to the halt of mitosis. The most important mechanism of inhibiting apoptosis by
XN consists of modulation of the expression of different pro-apoptotic factors, such as
caspases-3, -7, -8, and -9, and downregulating the expression of apoptosis regulator gene
B-cell lymphoma 2 (Bcl-2 ) [137].
XN is shown to have possible protective effects on brain disorders secondary to
aging [138]. In clinical trials, XN was observed to protect against the excessive production
of pro-inflammatory cytokines IL-1β and TNF-α and provided a balance between pro- and
anti-apoptotic factors in the brain, in a dose-dependent manner. In addition, XN was noted
to induce an increase in the expression of brain-derived neurotrophic factor, which may
lead to modulation of the inflammatory response in the brain. Aging increases the protein
and mRNA expression of the glial fibrillary acidic protein, an astroglia marker in the brain.
In recent trials, the administration of XN to mice showed a significant decrease in these
aging-related markers, suggesting that XN may have possible protective factors against
degenerative diseases [138].
As a nonspecific protein degradation pathway, autophagy is designed to control the
progression of cancer and neurodegenerative diseases. Recent research indicated that
autophagosome maturation of human epidermoid carcinoma A431 cells is restricted by XN.
This impairment is caused by the binding of XN to the N-domain of the valosin-containing
protein (VCP), which inhibits the action of VCP. VCP is an essential protein for autophagosome maturation [139]. The modulation of autophagy by XN is the main contributor to
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the mechanisms underlying the anticancer activity of XN, although further studies are
needed to illustrate whether this autophagy inhibits or facilitates the XN-induced apoptosis [134]. Angiogenesis is essential for tumor growth in the growing stages of cancer
and is characterized by the growth of new blood vessels to travel farther within the body.
Angiogenic factors include MMP and vascular endothelial growth factor (VEGF). Some
studies that focus on the antiangiogenic effects of XN portray that it has the ability to inhibit
important pathways by suppressing enzymes involved in the proliferation, endothelial cell
migration, and ultimately the angiogenesis of human microvascular endothelial cells in a
dose-dependent manner [137].
XN showed antioxidant activities by directly reducing ROS and indirectly inducing
the cellular defense mechanisms to overcome the oxidant stress [140–142]. Moreover, the
pharmacological targets for its bioactivity have been identified and investigated, including
Keap1 and NF-κB, as well as binding to the VCP and MRP5 [143,144]. Among these targets,
Keap 1 is an important target that is responsible for regulating autophagy and the antiaging
process [143,145].
In skin aging, there is degeneration of the extracellular matrix’s collagen and elastin
fibers, and from its reduced biosynthesis and increased degradation by elastase and MMPs.
Philips et al. evaluated XN’s ability to inhibit MMP-1, MMP-8, and elastase activity and to
stimulate biosynthesis of fibrillar collagens, elastin, and fibrillins in dermal fibroblasts [146].
XN was shown to prevent the loss of proteoglycan and collagen as well as the MMPdependent shedding of I-CAM in skin cell culture medium. These activities suggested a
role in reversing skin aging [147].
Although there are many in vivo and in vitro studies to demonstrating XN’s beneficial effects on human health, developing XN as a reliable drug can be challenging [148].
Extracting and isolating the pharmacological-relevant concentrations from food sources
are difficult due to its low solubility in water [135]. Similar to other phytochemical products, further studies need to be performed to develop XN as a reliable drug for specific
therapeutic applications.
4.4. Guggulsterone
Guggulsterone (GS) is a yellow resin isolated from a small thorny tree called Commiphora mukul. Widely used in Asian countries such as India, GS has traditionally served
as herbal medicine for inflammatory diseases for centuries [149]. GS is a plant sterol,
and its hypolipidemic effects have been well-studied in in vitro and in vivo animal models [150] [151]. Chander et al. reported cardioprotective effects of GS mediated through
the inhibition of ROS production in rodents [152]. Because ROS is one of the fundamental causes of oxidative stress, which is implicated in the aging process, GS’s capability
in decreasing ROS will serve as a strength against aging. In this study, the authors synthesized a synthetic guggulsterone (E and Z-isomers) and tested in human low-density
lipoprotein and rat microsomes in comparison to natural GS and gemfibrozil. The study
results suggested that GS inhibited oxidative degradation of lipids by counteracting against
the generation of superoxide anions and hydroxyl radicals [152]. Additionally, GS was
found to decrease cholesterol through antagonizing the farnesoid X receptor (FXR) [153].
Interestingly, GS increased the expression of FXR in 3T3-L1 adipocytes, suggesting that it
may act as an inverse agonist at low doses [154]. Likewise, in the same adipocyte model, GS
also increased the expression of transcriptional co-activator PGC1α [155], a key regulator of
mitochondrial biogenesis and a potential therapeutic target for age-related disorders [156].
GS serves as an antagonist for the FXR, an important nuclear receptor that regulates
an array of genes, such as bile acid expression, lipids, and, most importantly in our investigation, autophagy [157]. However, to greatly understand the role of GS as an antagonist of
FXR in increasing autophagy, it was hypothesized that GS will be able to increase autophagy
through the same mechanism in which it decreases cholesterol. Another study noted that
GS decreased cholesterol through antagonism of the FXR receptor, which increased the
expression of the bile salt export pump [158]. The bile salt export pump is a transporter that
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is mainly responsible for the excretion of bile salts into bile, which decreases the synthesis
of cholesterol in the liver. GS’s ability to increase the expression of the bile salt export pump
through the antagonism of the FXR shows that the compound was able to decrease cholesterol and demonstrate hypolipidemic effects. Similarly, autophagy is indirectly regulated
by FXR, in which the activation of FXR suppresses the process of autophagy in the liver. In
other words, the process of autophagy was increased through the antagonisms of the FXR.
Furthermore, skin health benefits of guggulsterone were discovered in in vitro and in vivo
studies [159,160]. Sarfaraz et al. discovered that the topical application of GS to SENCAR
mice resulted in a significant decrease in skin edema, hyperplasia, and classical markers
of inflammation and tumor promotion, such as COX-2 and iNOS. They found that the
topical application of GS induced inhibition of phosphorylation of MAPKs, activation of
NF-κB/p65 and IKKα/β, and degradation and phosphorylation of IκBα [160]. In addition,
Koo et al. showed that GS suppressed tyrosinase activity in B16 murine melanoma cells
and melanin biosynthesis which promotes longevity of melanin cells [159].
Despite the differences in the results across various studies, the collective data suggest
that GS has an inherent ability to produce beneficial antiaging effects. Although GS’s
potential is vast and promising, more studies and research are needed to investigate its
role in aging. While there are many studies regarding its effects on the conditions and
therapeutic effects that can indirectly be linked to the aging process, more extensive studies
need to be completed to investigate its direct effects on the aging process.
4.5. Resveratrol
Resveratrol is a natural polyphenol found in red wine and plants, such as plums,
grapes, and raspberries, and has been well-studied and found to work in multiple mechanisms and have a plethora of benefits [161]. One of the mechanisms by which resveratrol
works is through the facilitation of oxidative stress and mitochondrial dysfunction [161].
As previously discussed, these factors have been shown to contribute to the aging process through the free-radical and mitochondrial theories of aging [162,163]. A study that
combined resveratrol and exercise in old mice reported evidence of improved antioxidant
activity and decreased lipid peroxidation in the major organs [164]. The study noted the
varying effects on the organs and a need to design a better intervention, but the data
suggested that resveratrol and exercise is beneficial in the prevention of age-related diseases. Another study evaluated aging secondary to oxidative stress in rat cardiomyocytes
after treatment with resveratrol. In this study, treatment with resveratrol decreased the
concentration of NO in cardiomyocytes from 18.49% in 2 months to 62.67% in 8 months [165].
In addition, treatment with resveratrol caused a significant decrease in nitric oxide
oxidative stress markers and total lipoperoxidation during the aging process, thus concluding that the administration of resveratrol during the aging process may help decrease
oxidative stress.
Because resveratrol is a known antioxidant, it is no surprise that this compound has
been shown to produce protective effects by attenuating oxidative injury. One study highlighted that resveratrol is able to accomplish its protective effects through the activation
of TFEB which is a regulator of autophagy [166]. Human umbilical vein endothelial cells
(HUVECs) treated with resveratrol demonstrated increased TFEB activity. Furthermore,
the study concluded that resveratrol offered protective effects to HUVECs from oxidative damage by modulating autophagy in a TFEB-dependent manner. Resveratrol was
shown to modulate the acetylation state of proteins to regulate autophagy and promote
longevity [167–169]. The lifespan in C. elegans and mice were prolonged by resveratrol via
activation of the NAD+ -dependent deacetylase SIRT1. In these studies, researchers showed
that deletion and depletion of essential autophagy genes, such as bec-1 in C. elegans and
Atg7 in yeast and flies, resulted in a decreased lifespan of the organisms.
Natural compounds are continuously being studied because they are linked to many
health benefits. Resveratrol is a powerful antioxidant, and in recent studies, resveratrol
was studied in cosmetics, specifically its effect on human skin lightening [162]. As skin
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ages, there is a progressive decline in the function compared to healthy skin [170]. Healthy
skin appearance is expanding the cosmetics industries as the consumers have demanded
more skin care products that can maintain healthy-looking skin. In the study of resveratrol effects on skin, it was observed that resveratrol can whiten human skin and slow
down aging by a multitude of mechanisms [162]. Mechanisms include the inhibition of
catalyzation of human tyrosine, suppression of gene maturation of tyrosine, inhibition of
ROS, enhancement of cellular antioxidant capacity through Nrf2 mechanisms, attenuation
of inflammatory responses, and inhibition of MMP’s catalytic activity. Several studies
were conducted to evaluate the effects of resveratrol in humans with various health conditions. While a number of these studies demonstrated a decrease in oxidative stress with
resveratrol supplementation [171–173], others showed no effects [174,175]. Differences in
experimental design, including sample size and dose of resveratrol, might have contributed
to the contrasting results seen in various studies. Overall, clinical trials have shown that
resveratrol is well-tolerated and safe with very few reports of adverse effects [176–178].
4.6. Sulforaphane
Sulforaphane (SFN) is an isothiocyanate found in cruciferous vegetables, such as
broccoli and Brussel’s sprouts [179–181]. SFN has been well-studied as a chemo preventive
agent, as previous epidemiological studies indicate that dietary intake of these vegetables
may protect against cancer. In a study on SFN on Caco-2 cells with rapamycin, it was
highlighted that the chemo-preventative effects were enhanced by multiple mechanisms,
including Nrf2, human pregnane X receptor -mediated UGT1A1, UGT1A8, and UGT1A10
induction [182]. The results of the study indicated that during cancer initiation, SFN may
augment the detoxification and removal of carcinogens by regulating multiple signaling
pathways to suppress cell growth and induce cell death.
SFN majorly works by inducing the Nrf2 pathway and inhibiting NF-κB, thus activating the antioxidant and anti-inflammatory responses. In one study, SFN pre-treatment
was shown to attenuate oxidative stress and pro-inflammatory response, and thereby
modulate post-ischemic ventricular function in isolated hearts submitted to ischemia–
reperfusion [183]. A cardio-protective effect was found in another study in rats given
broccoli. The study was over a period of 30 days, with rats in isolated heart preparations
that resulted in reduced apoptosis and increased activity of antioxidant enzymes [184].
SFN’s ability to induce autophagy was studied using transmission electron microscopy
on sulforaphane-treated PC-3 (adenocarcinoma cell line) cells. SFN-treated cells displayed
key features of cells undergoing apoptosis, such as the formation of membranous vacuoles
and chromatin condensation in the nuclei [185]. This study reports that it is reasonable to
assume that SFN-induced apoptosis in human prostate cancer cells was derived from an
increase in autophagy activity as determined by their analysis of sub-diploid cells by flow
cytometry, following staining with propidium iodide [185]. The histograms resulted with
SFN treatment showed a 6-fold increase in apoptotic cells.
Although several studies show that SFN is able to reactivate the Nrf2 pathway, it was
only when enough SFN was in the tissues that the process activates. The concentrations
of SFN used were also taken into account with the various studies because different
SFN concentrations have different effects, depending on the cell type of the organism.
In particular, one study with red flour beetles reported that a diet supplemented with
1% w/w broccoli concentration increased the beetle’s longevity in conditions of external
stressors [184]. Transcription factor Nrf2 induced detoxification then led to increased stress
resistance for the flour beetles. In a phase II clinical trial, men with recurrent prostate cancer
were supplemented with a single daily dose of 200 µmol of SFN extracted from broccoli
sprouts for a period of 20 weeks. The dose was chosen because prior studies showed this
dose led to low micromolar intro-prostatic concentrations, displayed tolerability and safety
with similar doses of these extracts, and it was not sensible to treat with higher doses of
these extracts [184]. Although the goal of a greater than 50% PSA decrease was not met in
this study, SFN still showed effectiveness and is still being studied in additional trials. More
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pre-clinical studies are needed in order to determine the most effective dosing, but the two
studies we discuss here show promising potential for SFN to be used in pharmacotherapy.
More recent studies have investigated SFN’s antiaging effects and have discovered
that its mechanism is through preservation of proteostasis. This mechanism activates the
proteasome subunit PSMB5 through the upregulation of heat-shock proteins, specifically
Hsp27, which leads to increased cellular lifespan and prevention of neurodegeneration [186].
In a microarray analysis, it was shown that proteasome activity was attributed to the SFNmediated upregulation of Hsp27 [181]. Treatment with SFN enhanced the expression and
function of proteasome against oxidative stress. As SFN activates the heat-shock proteins
in the bodies, the proteins assist with slowing down the aging process. The gradual
deterioration in cells are usually induced by oxidative stress, and lately, there are studies
on SFN against cellular skin aging [187].
There are currently more studies going on to use SFN as a natural ingredient for
antiaging creams. Skin is sensitive against multiple external and internal factors, and
over time, its function and appearance deteriorate. SFN has also demonstrated protective
effects against ultraviolet-induced skin damage through several mechanisms of action
and the maintenance of collagen levels during photo-aging via the inhibition of the AP-1
activation and expression of metalloproteinases. Cell maturity is related to the progressive
rate of glucose metabolism through glycolysis and this is countered by SFN treatment [187].
Glycolytic restriction was previously found to delay senescence, and a study on SFN on
fibroblast senescence shows evidence of restricted cellular glucose uptake and increased
glycolysis. Overall, experimental findings show evidence of the benefits to SFN, but more
studies need to be investigated and performed to fully gauge the potential of SFN.
5. Conclusions
Evidence from different in vitro and in vivo studies demonstrated that there is a
positive correlation between the progress of aging and the decline in autophagy and
elevation of ROS. In other words, an impairment in autophagy or an imbalance of ROS
induces pathological aging and disease. Studies have shown that long-term health benefits
and antiaging effects may be achieved by promoting autophagy and suppressing oxidative
stress in various tissues and organisms.
Promising natural compounds that demonstrated antiaging effects through a modulating autophagy process and reducing ROS are reviewed in this article. The majority of
these chemicals demonstrated pharmacological effects via multiple molecular pathways.
To briefly summarize the mechanisms of each compound, the compounds are categorized
based on their mechanism of actions. CDDO and resveratrol upregulated the transcription
factor Nrf2 and TFEB, respectively, which caused the inhibition of mTOR pathways to
promote the initiation of the autophagy process. SFN and CAPE not only demonstrated
promoting the autophagy process by inducing Nrf2 and LC3 compounds but also showed
that these two compounds demonstrated a reduction in ROS in various organisms via
inhibiting NF-κB and upregulating the expression of autophagy-related genes such as Atg
7 and Beclin 1 (CAPE) and Hsp27 (SFN). The major antiaging mechanism for xanthohumol and guggulsterone was demonstrated by inhibiting NF-κB pathways and resulted in
anti-inflammatory effects and anti- oxidative stress in various organisms. The antiaging
mechanisms of those phytochemicals through regulating autophagy and oxidative stress
are summarized in Figures 2 and 3.
Many pharmacological drugs have been shown to induce changes in autophagy and
ROS, contributing to their health benefit; however, natural compounds are continuously
being investigated because they are linked to other health benefits. Although overwhelming evidence in the literature supports that the discussed natural compounds have the
potential for antiaging effects, further studies, including pre-clinical and clinical, need to
be performed to understand and identify specific drug targets and doses for therapeutic
intervention in antiaging effects.
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of NF-κB
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potential
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completion
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autophagy
process
[190].
Nrf2,
when bound
to regulate autophagic process by getting translocated into the nucleus to activate the transcription
ofto
Keap1, a major regulator of Nrf2, is quickly degraded but under oxidative stress, it gets released
target genes [191]. Phytochemicals
reviewed in this manuscript activate or inhibit multiple pathways
from Keap1 to regulate autophagic process by getting translocated into the nucleus to activate the
to modulate autophagy.
transcription of target genes [191]. Phytochemicals reviewed in this manuscript activate or inhibit

multiple pathways to modulate autophagy.

Figure 3. Phytochemicals inhibit OS-induced aging. Imbalance between the free radicals and anti-
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aging.
Many
pharmacological
drugs have been shown to induce changes in autophagy and
ROS, contributing to their health benefit; however, natural compounds are continuously
being investigated because they are linked to other health benefits. Although overwhelming evidence in the literature supports that the discussed natural compounds have the
potential for antiaging effects, further studies, including pre-clinical and clinical, need to
be performed to understand and identify specific drug targets and doses for therapeutic
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130. Serarslan, G.; Altuğ, E.; Kontas, T.; Atik, E.; Avci, G. Caffeic acid phenetyl ester accelerates cutaneous wound healing in a rat
model and decreases oxidative stress. Clin. Exp. Dermatol. Exp. Dermatol. 2007, 32, 709–715. [CrossRef] [PubMed]
131. Kavakli, H.S.; Alici, O.; Koca, C.; Ilhan, A.; Isik, B. Caffeic acid phenethyl ester decreases oxidative stress index in blunt spinal
cord injury in rats. Hong Kong J. Emerg. Med. 2010, 17, 250–255. [CrossRef]
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